SCHEMBL4933637

SCHEMBL4933637

O=C(Cc1csc(Nc2ccc(Cl)c(C(F)(F)F)c2)n1)Nc1nccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ DHODH Q02127 1/20 0.46
▸ GRM4 Q14833 1/20 0.45
▸ FFAR2 O15552 1/20 0.45
▸ KCNJ5 P48544 1/20 0.44
▸ KCNJ3 P48549 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CTPS1 P17812 1/20 0.44
▸ PDE5A O76074 1/20 0.43
▸ KDR P35968 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ BLM P54132 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ PIK3C2B O00750 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ PIK3C2G O75747 1/20 0.41
▸ CDK1 P06493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14069855 0.89 KCNJ5 (0.56) MAPTKMT2AMEN1DHODHGRM4
SCHEMBL14069860 0.87 BLM (0.49) MAPTKMT2AMEN1DHODHGRM4
SCHEMBL14069895 0.85 MAPT (0.52) MAPTKMT2AMEN1DHODHKCNJ5
SCHEMBL14069875 0.85 MAPT (0.53) MAPTKMT2AMEN1DHODHGRM4
SCHEMBL14640549 0.85 CYP1A2 (0.53) MAPTKMT2AMEN1DHODHKCNJ5
SCHEMBL4933898 0.85 DHODH (0.52) MAPTKMT2AMEN1DHODHKCNJ5
SCHEMBL5591452 0.84 MAPT (0.54) MAPTKMT2AMEN1DHODHGRM4
SCHEMBL14070045 0.84 DHODH (0.51) MAPTKMT2AMEN1DHODHKCNJ5
SCHEMBL4929143 0.83 MAPT (0.51) MAPTKMT2AMEN1DHODHKCNJ5
SCHEMBL14069894 0.83 DHODH (0.52) MAPTKMT2AMEN1DHODHKCNJ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 — — US disclosed
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 — — US disclosed
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 — — US disclosed
WO-2007002461-A1 3,4-SUBSTITUTED THIAZOLES AS AMPK ACTIVATORS DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators PRKAG3, PRKAG1, PRKAG2 MAPT 2742/4885KMT2A 3233/4885MEN1 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback